payor coverage
Iovance Records First Amtagvi Revenue in Q2 Following FDA Approval
The firm provided updates on the commercial launch of the first autologous cell therapy to enter the commercial market for a solid tumor.
German Public Health Insurance Sets €15.5M Budget Increase for Genetic Diagnostic Services
The decision follows an annual review of human genetic services in Germany that found their volume continues to rise.
Cell and Gene Therapy Pricing Model Remains Sticking Point Despite CMS Efforts to Defray Costs
Premium
Despite some CMS policies designed to improve patient access to cell and gene therapies, the reliance on a value-based pricing model drew sharp criticism in an ASGCT session.
Sickle Cell Gene Therapy Fertility Risks Spur Calls for Changes Allowing Industry Support Services
Gene therapy companies aren't covering fertility preservation for Medicaid patients due to anti-kickback laws, but CMS is exploring solutions in a model.
Clarified Precision Medicine Sees Seed Investment as Sign the Market Recognizes 'Last Mile' Gaps
Premium
The company, which helps oncologists translate complex biomarker testing results into clinical decisions, recently closed a $1.2 million seed financing round.
Feb 21, 2024